Richter syndrome has been defined as the transformation in a high-grade non-Hodgkin lymphoma, prolymphocytic leukemia, Hodgkin disease, or acute leukemia supervening in the course of B-CLL or small lymphocytic lymphoma.3This secondary high-grade lymphoma, usually with diffuse large B-cells, develops in approximately 2.2% to 8% of patients.3It occurs mostly in lymph nodes and may represent a second neoplasm or a transformation from the same lymphocytic clone population in the course of B-CLL. Clinically, it is often characterized by sudden deterioration of general conditions and development of systemic symptoms such as fever, weight loss, night sweating, and other rare symptoms related to localization of disease. Therapy so far proved unsuccessful, and the overall duration of survival for patients is approximately 5 to 8 months after Richter transformation.3Extranodal localizations are uncommon; the more frequent cases in the literature include involvement of the central nervous system, skin, eye, testis, lung, kidneys, and gastrointestinal tract. In particular, gastrointestinal tract involvement is observed in only 5.1% of cases and affects mostly gastric and colonic sites.4- 5